Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The public trial brought to general light some questionable analysis

TPL uses when notifying an infringing target of their potential financial exposure. Aside from the Apple royalty rate debacle and some of those other events that we on this board were able to uncovered ourselves, I now more clearly understand why the MMP licensing program has had difficulties being cooperated with, and why I believe the good faith negotiations credibility of both TPL and Alliasence has been rightly questioned; and imo permenantly damaged.

In my opinion, unless genuine substantive changes are made to the method in which we notify and negotiate with prospective licensees, future MMP licensing efforts will likely continue to be marginalized, resisted or even confronted in Court.

I highly recommend that PDS, with authority as the appointed Licensor, revamp the method that future licenses are negotiated. I also suggest that Carl Johnston, as the Manager of PDS, find some arrangement to fill the "Independent" seat on the PDS Board with Mr Otteson, and to manage some accomodation whereby Otteson and not Alliasence would do more contact/negotiations; with Alliasence stepping back and providing mainly research, engineering and technical support. PDS was contractually constituted to have 3 BOD members, and by apparent agreement of the JV partners, TPL and PTSC mutually agreed to waive that provision. If PTSC refuses to continue to waive the 3 member requirement, TPL cannot prohibit the third seat from being filled by a mutually acceptable individual. Otteson just coming off the HTC win, and being our (hopefully future) legal muscle, would provide tremendous weight and efficency in being an actual entity in the Licensing team process, and not just be perceived as a hired gun at the point of threatened litigation.

I realize that in practice this may be problematic from a mechanics, ethics, or some other points of view, but I suspect that if the MMP can truely produce the kinds of more reasonable license fees that are hoped for, and do it within the limited remaining time we have for patent protection and patent prosecution; that all concerned parties can find some way to make it happen, and benefit by what I feel would be a much more effective, efficient and cooperative Licensing program. This would not stop lawsuits for any targets which might be exposed to truly huge damage amounts and require that type of aggressiveness, but it will, imo, make acceptence, compliance, and efficency far far greater for those other 400 (so far) Infringers.
Share
New Message
Please login to post a reply